Previous Article | Next Article ![]()
Molecular and Cellular Biology, April 2004, p. 3277-3285, Vol. 24, No. 8
0270-7306/04/$08.00+0 DOI: 10.1128/MCB.24.8.3277-3285.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Division of Biological Science, Graduate School of Science, Nagoya University, Chikusa-ku, Nagoya 464-0814, Japan
Received 10 September 2003/ Returned for modification 4 November 2003/ Accepted 19 January 2004
| ABSTRACT |
|---|
|
|
|---|
or kinase-negative mec1 mutation. Mec1 phosphorylated the S/TQ motifs of Rad9 in vitro, the same motifs that are phosphorylated after DNA damage in vivo. In addition, multiple mutations in the Rad9 S/TQ motifs resulted in its defective association with DSBs. Phosphorylation of Rad9 was partially defective in cells carrying a weak mec1 allele (mec1-81), whereas its association with DSBs occurred efficiently in the mec1-81 mutants, as found in wild-type cells. However, the Rad9-Rad53 interaction after DSB induction was significantly decreased in mec1-81 mutants, as it was in mec1
mutants. Deletion mutation in RAD53 did not affect the association of Rad9 with DSBs. Our results suggest that Mec1 promotes association of Rad9 with sites of DNA damage, thereby leading to full phosphorylation of Rad9 and its interaction with Rad53. | INTRODUCTION |
|---|
|
|
|---|
DNA damage checkpoint pathways transmit signals through evolutionarily conserved kinases (39). These kinases include the family of high-molecular-weight protein kinases, i.e., ATM (mammals), ATR (mammals), MEC1 (the budding yeast Saccharomyces cerevisiae), TEL1 (budding yeast), and rad3+ (the fission yeast Schizosaccharomyces pombe) (1). Each of these genes falls into two family groups based on homology; ATM is related most closely to TEL1, while ATR is more closely related to MEC1 and rad3+. These large protein kinases regulate the activation of two downstream protein kinases, represented by mammalian Chk1 and Chk2 (1, 39). Chk2 contains a forkhead-associated (FHA) domain, and Chk2 homologs are encoded by RAD53 and cds1+ in budding yeast and fission yeast, respectively (39). Kinases related to mammalian Chk1 have been identified and called Chk1 in budding yeast and fission yeast (39).
In budding yeast, Mec1 plays a critical role in the DNA damage checkpoint controls throughout the cell cycle (14), whereas Tel1 plays a minor role (17, 20, 28). Mec1 physically interacts with Ddc2 (also called Lcd1 and Pie1), a protein that exhibits limited homology to the fission yeast Rad26 and mammalian ATRIP proteins (2, 5, 21, 24, 35). Mec1 and Ddc2 function as a complex and localize to sites of DNA damage, suggesting that the Mec1-Ddc2 complex interacts with aberrant DNA structures or the DNA repair apparatus after DNA damage (13, 16, 25). Recent evidence supports the model in which Ddc2 binds to replication protein A (RPA)-coated single-stranded DNA (ssDNA) and thereby the Mec1-Ddc2 complex localizes to sites of DNA damage (40). Mec1 regulates the phosphorylation and activation of the Rad53 and Chk1 protein kinases (27, 28, 31). Rad53 plays a critical role in DNA damage checkpoints throughout the cell cycle (14), whereas Chk1 acts in the G2/M-phase cell cycle arrest in response to DNA damage (27). Thus, the Mec1 and Rad53 kinases constitute a central DNA damage checkpoint pathway.
Phosphorylation and activation of Rad53 is also controlled by DDC1, MEC3, RAD17, and RAD24 (14). Genetic evidence has suggested that RAD17, RAD24, MEC3, and DDC1 operate in the same pathway (14). DDC1, MEC3, and RAD17 are homologs of the mammalian RAD9, HUS1, and RAD1 genes, respectively, each of which encodes a protein structurally related to PCNA (39). Consistently, Ddc1, Mec3, and Rad17 form a PCNA-related complex and function as a complex (12). RAD24 is related to the RAD17 gene in mammals and encodes a protein structurally similar to the subunits of replication factor C (RFC) (39). Rad24 interacts with the four small RFC subunits, Rfc2, Rfc3, Rfc4, and Rfc5, to form an RFC-related complex (10, 18). The Rad24 complex regulates the recruitment of the Ddc1-Mec3-Rad17 complex to sites of DNA damage (13, 16).
RAD9 is the prototype DNA damage checkpoint gene (36) and is required for the phosphorylation and activation of Chk1 and Rad53 (9, 27, 29). Rad9 is related to Crb2 in fission yeast, although no clear mammalian homolog has been identified (39). Rad9 is phosphorylated after DNA damage in a manner dependent on Mec1 and Tel1 (7, 34). Members of the ATM and ATR kinase families phosphorylate serine or threonine in S/TQ motifs (1). Consistently, multiple S/TQ motifs within Rad9 are phosphorylated in response to DNA damage (29). Moreover, multiple mutations in the Rad9 S/TQ motifs cause a defect in the activation and phosphorylation of Rad53 after DNA damage (29). In addition to Mec1 and Tel1, the Rad17 and Rad24 complexes contribute to Rad9 phosphorylation after DNA damage (7, 34). Phosphorylated Rad9 interacts physically with Rad53 in vivo (7, 32, 34). Rad53 contains two FHA domains, which have the ability to bind to specific phosphopeptides. Both of the Rad53 FHA domains can interact with Rad9 phosphopeptides (4, 29), and mutations of conserved amino acids in the second FHA domain abolish the DNA damage-induced Rad53 phosphorylation (32). Furthermore, phosphorylated Rad9 facilitates the activation and phosphorylation of Rad53 in vitro (9). These data have supported the model in which phosphorylated Rad9 acts as machinery to interact with the Rad53 FHA domain and activate the Rad53 kinase. Thus, phosphorylation of Rad9 after DNA damage is a crucial step in the transduction of the checkpoint signal. Because Mec1 localizes to sites of DNA damage, it is possible that Mec1 phosphorylates Rad9 at DNA damage sites. Previously, Rad9 was shown to form foci in the presence of DNA damage (16) and associate with replication origins when DNA replication and damage checkpoints have deteriorated (11). However, whether Rad9 is recruited to sites of DNA damage has not been clearly demonstrated.
In this study, we found that Rad9 associates with double-strand break (DSB) lesions and that its association requires Mec1 kinase activity. We found that Rad9 associated with DSBs in wild-type cells but not in cells carrying mec1
or kinase-defective mec1 mutations. Mec1 phosphorylated serine or threonine of the Rad9 S/TQ motifs in vitro, residues that are required for DNA damage-induced phosphorylation of Rad9 in vivo. Accordingly, mutations in the S/TQ motifs caused a defect in the association of Rad9 with DSBs. Rad9 associated with DSBs in cells carrying a weak mec1 mutation as efficiently as in wild-type cells, although phosphorylation of Rad9 was partially decreased in the mec1 mutants. Our results suggest that Mec1 promotes association of Rad9 with sites of DNA damage and then fully phosphorylates Rad9 at the damage sites.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Strains.
The RAD9-HA::TRP1 strains were obtained by transforming YIp-RAD9-HA after treatment with PshAI and replacing the LEU2 marker with TRP1. The RAD53-HA::TRP1 strains were obtained by transforming YIpT-RAD53-HA after treatment with SacI. The rad97XA-HA::TRP1 strains were constructed by transformation of YIp-RAD97XA-HA after treatment with SnaBI. The mec1-KN-HA strain was generated by transformation with PCR products amplified with pWJ1077 (23) in combination with YEp-MEC1-KN-HA (35) as previously described (23). Construction of cells carrying MATa-inc and ADH4cs::HIS2 was described previously (19). The mec1-81-HA strains were constructed with YIp-MEC1-HA as previously described (35). The mec1-81, rad17
::LEU2, rad24
::LEU2, rad53
::LEU2, sml1
::LEU2, and tel1
::KanMX mutations were described elsewhere (20, 30, 35). All of the strains used in this study are isogenic to KSC006 (30) and are listed in Table 1.
|
Measurement of DSB processing. Yeast cells were precultured in medium containing 2% sucrose and then arrested with 15 µg of nocodazole per ml for 120 min at G2/M. To induce HO expression, galactose was added to a final concentration of 2%. Purified DNA was fixed to a positively charged nylon membrane and probed with sequences complementary to DNA strands near the HO restriction site at the ADH4 locus as previously described (19). Cleavage at the ADH4 locus was confirmed by Southern blot analysis (13).
In vitro kinase assay.
In vitro kinase assay of Mec1 was done as described previously (20, 30). Kinase assay for Mec1 was performed in 40 µl of kinase buffer by the addition of 10 mCi of [
-32P]ATP (3,000 Ci/mmol; Amersham Pharmacia Biotech), substrate [2 µg of glutathione S-transferase (GST)-RAD9(S/TQ) or GST-RAD9(AQ) and 0.6 µg of PHAS-1], and ATP to 100 µM.
Chromatin immunoprecipitation assay. A chromatin immunoprecipitation assay was performed essentially as previously described (19). Yeast cells were precultured in medium containing 2% sucrose and then arrested with 15 µg of nocodazole per ml for 120 min. To induce HO expression, galactose was added to a final concentration of 2%. Immunoprecipitation of cross-linked DNA was performed after sonication with anti-HA (12CA5) monoclonal antibodies. DNA was also purified from the whole-cell extract (designated "input"). PCR was performed under nonsaturating conditions, in which the rate of PCR amplification is proportional to the substrate concentration and cycling. The sequences of the primers for the HO1 set at the ADH4 locus are 5'-TCTATTAATGAGCCGAGACCGGTA-3' and 5'-CGCATGTGAATGACACACGAAAGT-3', those for the HO2 set at the ADH4 locus are 5'-CATTATTCTCGGAAGTAGAGTCGA-3' and 5'-TTCGCGAGAAGAAGGTACATGATC-3', and those for the SMC2 locus are 5'-AAGAGAAACTTTAGTCAAAACATGGG-3' and 5'-CCATCACATTATACTAACTACGG-3'.
| RESULTS |
|---|
|
|
|---|
|
Effect of the mec1
or tel1
mutation on association of Rad9 with DSBs.
DNA damage-induced phosphorylation of Rad9 is dependent on Mec1 and Tel1 (7, 34). We therefore tested whether HO-induced Rad9 phosphorylation requires Mec1 and/or Tel1 in G2/M-arrested cells (Fig. 2A). Because the lethality of the mec1 disruption is suppressed by sml1 mutation (38), we examined the effect of the mec1
mutation in an sml1
background. Rad9 was phosphorylated in tel1
mutants similar to wild-type cells after HO expression, but phosphorylation was not detected in mec1
mutants. Treatment with 4-nitroquinoline-1-oxide is known to induce phosphorylation of Rad9 in a process dependent on Tel1, and partial phosphorylation of Rad9 is observed in mec1
cells (7). Consistently, Rad9 was partially phosphorylated in the same mec1
mutant strain after treatment with 4-nitroquinoline-1-oxide at G2/M (data not shown). Thus, Mec1 is essential for the HO-induced phosphorylation of Rad9, whereas Tel1 has little involvement.
|
and tel1
mutants (Fig. 2B). Association of Rad9 with the DSB was significantly decreased in mec1
mutants compared to that in wild-type cells, whereas no apparent defect was detected in tel1
mutant cells. The decreased association of Rad9 with DSBs in mec1
mutants would be explained if the Rad9 protein localized to the nucleus and its cellular localization might be affected by the mec1
mutation. To exclude this possibility, we examined the intracellular distribution of Rad9 in wild-type and mec1
cells (Fig. 2C). Whole-cell extracts were fractionated into two separate cytoplasmic and nuclear fractions. Equal-volume aliquots of these fractions and whole-cell extract were analyzed on immunoblots to detect Rad9-HA. As a control for the fractionation, we assessed each fraction for the presence of cytoplasmic glucose-6-phosphate dehydrogenase and a nuclear pore complex protein. Most Rad9 proteins were separated in the nuclear fractions in wild-type cells, consistent with the previous finding that Rad9 is predominantly localized to the nucleus (16). Rad9 was fractionated to nuclei in mec1
mutants as well. Thus, the mec1
mutation does not affect the cellular localization of Rad9. To address whether Mec1 kinase activity is important, we examined the Rad9 association in cells carrying a kinase-negative mec1 allele (mec1-KN mutants) (35). We found that phosphorylation of Rad9 and its association with DSBs were not detectable in mec1-KN mutants (Fig. 2A and B). Altogether, these results suggest that Mec1 kinase activity is essential for HO-induced Rad9 phosphorylation and association of Rad9 with the HO-induced DSB.
Rad9 is homologous to Crb2 of fission yeast, whereas Mec1 is closely related to fission yeast Rad3. Recently, Du et al. (3) showed that accumulation of Crb2 at sites corresponding to DSBs can be separated into two steps, i.e., initial recruitment and continued retention, and that Rad3 controls the retention of Crb2 at DSBs. We therefore addressed whether association of Rad9 with DSBs might be regulated in a similar manner. If Mec1 controlled the retention of Rad9, transient association of Rad9 with DSBs could be detected in mec1
mutants while Rad9 recruitment is in progress. Alternatively, if Mec1 controlled the recruitment of Rad9, no Rad9 association should be detected in mec1
mutants. To define the Rad9 recruitment process, we extended the time course analysis examining the association of Rad9 after HO expression. Rad9 association reached a plateau at 3 h after HO expression (Fig. 2D), suggesting that Rad9 is actively recruited to the DSB within 3 h after HO expression. In contrast, no apparent association was detected in mec1
mutants during the time course (Fig. 2D). Southern blot analysis indicated that the cleavage at the ADH4 locus occurred within 1 h after HO expression in both wild-type and mec1
mutant cells (data not shown). These results suggest that Mec1 is required for Rad9 recruitment to DSBs. However, it remains possible that Mec1 controls Rad9 retention because our assay might not be sensitive enough to detect transient association of Rad9 with DSBs in mec1
mutant cells.
Effects of mutations in S/TQ motifs on the association of Rad9 with DSBs. Rad9 contains a total of 14 S/TQ motifs, which are consensus sites of phosphorylation by the ATM and ATR family proteins (1). Recent evidence demonstrated that seven serine or threonine residues (Thr390, Thr398, T410, T420, S435, T457, and T603) within the S/TQ motifs are redundantly required for DNA damage-induced phosphorylation (29). The Rad97XA mutant protein, in which these seven serine and threonine residues are all replaced with alanine, is very poorly phosphorylated after DNA damage and is defective in checkpoint activation.
To further address the possibility that phosphorylation of Rad9 is required for its association with the HO-induced DSB, we examined whether the rad97XA mutation affects HO-induced phosphorylation and association of Rad9 with the DSB (Fig. 3). We found that, in contrast to wild-type Rad9, Rad97XA did not become phosphorylated after HO expression (Fig. 3A). Moreover, association of Rad97XA with the HO-induced DSB was significantly decreased (Fig. 3B). Rad97XA was fractionated into the nuclear fraction similarly to wild-type Rad9 (data not shown). These results indicate that the rad97XA mutation causes a defect in the association of Rad9 with the HO-induced DSB.
|
mutants, suggesting that Mec1 might directly phosphorylate the Rad9 S/TQ motifs in vitro. To test this, we made two GST-Rad9 fusion proteins: GST-RAD9(S/TQ), which contains the seven S/TQ motifs, and GST-RAD9(AQ), which possesses the same region but replaces serine or threonine in the motifs with alanine. PHAS-1 was used as a control substrate (15, 20) and incubated together with GST-RAD9(S/TQ) or GST-RAD9(AQ). Extracts were prepared from cells expressing the wild-type Mec1-HA or kinase-negative Mec1-KN-HA protein and immunoprecipitated with anti-HA antibodies. Immunoprecipitates were then subjected to a kinase assay. We found that GST-RAD9(S/TQ) and PHAS-1 were phosphorylated in immunoprecipitates containing Mec1-HA but not in those containing Mec1-KN-HA (Fig. 3C). In contrast, no specific phosphorylation of GST-RAD9(AQ) was observed with Mec1-HA (Fig. 3C). Thus, Mec1 phosphorylates serine and threonine residues of the Rad9 S/TQ motifs in vitro. Together, these data support a model in which Mec1 phosphorylates the S/TQ motifs and then facilitates the association of Rad9 with DSBs. Effect of the mec1-81 mutation on the phosphorylation of Rad9 and its association with DSBs. Since Mec1 controlled the phosphorylation of Rad9 and its association with DSBs, it is possible that the association of Rad9 with DSBs is coupled with its phosphorylation status. If this were the case, both phosphorylation of Rad9 and its association would be reduced in cells carrying weak mec1 mutation alleles. To test this possibility, we examined the phosphorylation of Rad9 and its association with DSBs in mec1-81 mutant cells (20) (Fig. 4A and B). The Rad9 phosphorylation level in mec1-81 mutants was low compared with that in wild-type cells, and fully modified Rad9 was not detected in the mec1-81 mutants (Fig. 4A). However, no significant defect in the association of Rad9 with DSBs was detected in mec1-81 mutants (Fig. 4B).
|
Relationships among Mec1-dependent phosphorylation, DSB binding, and interaction with Rad53.
Hyperphosphorylation of Rad9 leads to its physical interaction with the Rad53 kinase (7, 32, 34). Recent studies have implicated the Rad9-Rad53 complex as machinery that activates Rad53, thereby facilitating Rad53 autophosphorylation (9). Rad53 phosphorylation after DNA damage is decreased in mec1-81 mutants similar to mec1
mutants (19). Correspondingly, no apparent Rad53 phosphorylation was detected in mec1-81 or mec1
mutants after HO expression (Fig. 5A) (19). To assess the functional link of Rad9 to Rad53 activation, we examined the physical interaction between Rad9 and Rad53 in mec1
and mec1-81 mutants after HO expression (Fig. 5B). Cells expressing HA-tagged Rad9 and myc-tagged Rad53 were transformed with the GAL-HO plasmid and grown as described above to induce HO expression. Extracts were prepared from cells and then subjected to immunoprecipitation with anti-myc antibodies. Consistent with the current model in which Rad53 interacts with phosphorylated Rad9, Rad53 was immunoprecipitated with Rad9 in wild-type cells after HO expression, whereas no Rad9-Rad53 interaction was detected in mec1
mutants. In contrast, Rad9 was phosphorylated, albeit weakly, in mec1-81 mutants, but the Rad9-Rad53 interaction was significantly reduced in mec1-81 mutants, as observed in mec1
mutants.
|
mutants. The effect of the rad53
mutation was monitored in an sml1
background, because sml1 mutations suppress the lethality of the rad53 disruption (38). Rad9 associated with the HO-induced DSB in rad53
mutant cells as efficiently as in wild-type cells (Fig. 6A). Consistently, the rad53
mutation did not significantly affect Rad9 phosphorylation (Fig. 6B) (7, 34). Together, these results suggest that the Rad9-Rad53 interaction occurs efficiently after Rad9 associates with DSBs and becomes fully phosphorylated in a Mec1-dependent manner.
|
mutation on the association of Rad9 with DSBs.
Rad24 forms an RFC-related complex and recruits the Rad17-Mec3-Ddc1 complex to sites of DNA damage. These Rad24, Rad17, Mec3, and Ddc1 proteins are also required for Rad9 phosphorylation after DNA damage. We then examined Rad53 phosphorylation and association with DSBs in rad24
mutants after HO expression. Consistent with the previous results (7, 34), the Rad9 phosphorylation level in rad24
mutants was partially decreased compared with that in wild-type cells (Fig. 7A). Moreover, association of Rad9 with the HO-induced DSB was lowered in rad24
mutants (Fig. 7B). Similar results were obtained with rad17
mutants (data not shown). These results indicate that the Rad24 pathway is required for efficient association of Rad9 with the HO-induced DSB.
|
mutation on accumulation of ssDNA at DSB ends.
Recently, Zhou and Elledge (40) provided evidence that ATRIP or Ddc2 binds to RPA-coated ssDNA, thereby recruiting the ATR-ATRIP or Mec1-Ddc2 complex to sites of DNA damage. DSB ends are degraded primarily by 5'-to-3' exonuclease activity, producing long 3'-end ssDNA tails (37). As shown above, association of Rad9 with DSBs is significantly decreased in mec1
mutants. If Rad9 interacts with ssDNA at DSBs, it is possible that ssDNA accumulation at the DSB end is reduced in mec1
mutants compared with that in wild-type cells. We then examined the degradation rate following HO expression from the galactose-inducible GAL10 promoter in G2/M-arrested cells (Fig. 8). Cells carrying the GAL-HO plasmid were grown as described above to induce HO expression. Cells were collected at various times to prepare genomic DNA. Purified DNA was fixed to a membrane and probed with strand-specific sequences near the cleavage site at the ADH4 locus. The 5'-to-3' degradation occurred in mec1
mutants as efficiently as in wild-type cells (Fig. 8A). Moreover, the mec1
mutation had little effect on the rate of 3'-to-5' degradation (Fig. 8B). Thus, the mec1
mutation does not impair the DNA degradation at the DSB end, suggesting that ssDNA accumulation by itself does not promote association of Rad9 with DNA lesions.
|
| DISCUSSION |
|---|
|
|
|---|
To examine whether Rad9 associates with sites of DNA damage, we used strains carrying a single HO cleavage site, in which the HO-induced DSB is not efficiently repaired by homologous recombination. We found that Rad9 associated with the HO-induced DSB and that its association required Mec1 function. Rad9 contains 14 S/TQ motifs throughout its entire length, motifs that are potentially phosphorylated by ATM and ATR family proteins Mec1 and Tel1. Although any single mutation of the Rad9 S/TQ motifs does not have a significant effect, replacement of the seven S/TQ motifs in the Rad9 central region confers a defect in Rad9 phosphorylation after DNA damage (29). Notably, these multiple replacements in Rad9 caused a defect in its association with DSBs. In addition, Mec1 phosphorylated these Rad9 S/TQ sites in vitro. These results are consistent with the model in which Mec1 phosphorylates S/TQ motifs of Rad9 and promotes its association with sites of DNA damage. However, we cannot exclude the possibility that the replacement-containing Rad97XA mutant protein might be misfolded or debilitated so that it has lost the initial DSB-binding capacity independently of its phosphorylation status (see below). Phosphorylation of the seven S/TQ motifs has been shown to contribute to the interaction with Rad53 (29). Our results here suggest that their phosphorylation is also important for association with sites of DNA damage.
Mec1 promotes the association of Rad9 with DSBs, but Mec1 by itself associates with sites of DNA damage (40). If Mec1 and Rad9 were colocalized, Mec1 could efficiently phosphorylate Rad9. It is thus possible that association of Rad9 with DNA lesions precedes full phosphorylation. Supporting this possibility, we found that Rad9 associated efficiently with DSBs, but its phosphorylation was partially decreased in mec1-81 mutants. We note, however, that the chromatin immunoprecipitation assay might not be as sensitive as the immunoblotting analysis, and thereby a slight decrease in the association of Rad9 could not be detected in mec1-81 mutants. The Mec1-81 mutant protein showed decreased kinase activity in vitro. These results suggest that although all of the S/TQ motifs of Rad9 could be phosphorylated after DNA damage, phosphorylation of some motifs might be sufficient for association of Rad9 with DNA lesions.
Phosphorylated Rad9 interacts with Rad53 through the Rad53 FHA domain (32), and this Rad9-Rad53 interaction is implicated in the activation and phosphorylation of Rad53 (7, 9, 32, 34). Rad9 was phosphorylated after HO expression in wild-type cells but not in mec1
mutant cells. Correspondingly, Rad9 interacted with Rad53 in wild-type cells but not in mec1
mutant cells. Rad9 is phosphorylated, albeit weakly, after HO expression in mec1-81 mutant cells, but the Rad9-Rad53 interaction was undetectable in these mutant cells. These results suggest that full phosphorylation of Rad9 is important for efficient interaction of Rad9 with Rad53. However, it remained possible that Rad53 binds to specific sets of phosphopeptide sequences of Rad9, and phosphorylation of those sites is defective in mec1-81 mutant cells.
The RAD24, RAD17, MEC3, and DDC1 genes constitute a DNA damage response pathway. Indeed, Rad24 forms an RFC-related complex and recruits the Rad17-Mec3-Ddc1 complex to sites of DNA damage. These Rad24, Rad17, Mec3, and Ddc1 proteins have been shown to regulate Rad9 phosphorylation after DNA damage. Consistently, Rad9 phosphorylation after HO expression was partially decreased in rad24
mutants. Although the mec1-81 mutation did partially decrease Rad9 phosphorylation after HO expression, it did not apparently affect the association of Rad9 with DSBs. In contrast, rad24
mutation reduced the association of Rad9 with DSBs as well. One likely explanation is that phosphorylated sites on Rad9 are different in mec1-81 and rad24
mutants. Although similar partial phosphorylation occurs after HO expression, phosphorylation involved in DSB binding might be decreased in rad24
mutants, but not in mec1-81 mutants. Alternatively, the rad24
mutation might affect DNA structure or proteins localizing at sites of DNA damage, thereby reducing the association of Rad9 with the damage sites.
Fission yeast checkpoint protein Crb2 is related to budding yeast Rad9. Recently, Du et al. (3) demonstrated that Crb2 localizes to foci that represent sites of DSBs. In fission yeast, Rad3 is structurally and functionally similar to budding yeast Mec1. Crb2 foci are induced after gamma irradiation in cells lacking Rad3, but the foci disappear immediately in the mutant cells. Thus, Rad3 is required not for the initial recruitment of Crb2 to sites of DNA damage but for its persistent localization. Since Crb2 and Rad9 are related each other, it seems likely that these proteins are regulated similarly. In this scenario, Rad9 could be recruited to DNA lesions independently of Mec1, and after Mec1-dependent phosphorylation, Rad9 would associate stably with the DNA lesions. However, our results suggest that Mec1 may control the recruitment of Rad9 to DSBs. One possible explanation is that recruitment of Rad9 is entirely coupled to its retention at DSBs in budding yeast. Similar to Rad9, Crb2 is phosphorylated after DNA damage, and its damage-induced phosphorylation is dependent on Rad3 (26). Conversely, our results imply that phosphorylation of Crb2 is required for its retention at DNA lesions.
Recent evidence suggests that checkpoint proteins have the ability to bind to ssDNA, thereby associating with DNA lesions (40). However, ssDNA accumulation was little affected in mec1
mutants, which exhibited a defect in the association of Rad9 with DSBs. Thus, ssDNA alone does not appear to promote association of Rad9 with DNA lesions, although ssDNA might be involved with the association.
In summary, we showed that Rad9 associates with sites of DNA damage and that its association is controlled by Mec1. However, it remains undetermined what DNA structure or protein connects Rad9 to sites of DNA damage. Moreover, it is unclear how phosphorylated Rad9 at DNA lesions mediates signals to downstream targets. Further experiments will be aimed at understanding the biochemical properties of Rad9 at sites of DNA damage.
| ACKNOWLEDGMENTS |
|---|
This work was supported by grants-in-aid from the Ministry of Education and Science of Japan.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Cortez, D., S. Guntuku, J. Qin, and S. J. Elledge. 2001. ATR and ATRIP: partners in checkpoint signaling. Science 294:1713-1716.
3. Du, L. L., T. M. Nakamura, B. A. Moser, and P. Russell. 2003. Retention but not recruitment of Crb2 at double-strand breaks requires Rad1 and Rad3 complexes. Mol. Cell. Biol. 23:6150-6158.
4. Durocher, D., J. Henckel, A. R. Fersht, and S. P. Jackson. 1999. The FHA domain is a modular phosphopeptide recognition motif. Mol. Cell 4:387-394.[CrossRef][Medline]
5. Edwards, R. J., N. J. Bentley, and A. M. Carr. 1999. A Rad3-Rad26 complex responds to DNA damage independently of other checkpoint proteins. Nat. Cell Biol. 1:393-398.[CrossRef][Medline]
6. Elledge, S. J. 1996. Cell cycle checkpoints: preventing an identity crisis. Science 274:1664-1672.
7. Emili, A. 1998. MEC1-dependent phosphorylation of Rad9p in response to DNA damage. Mol. Cell 2:183-189.[CrossRef][Medline]
8. Gietz, R. D., and A. Sugino. 1988. New yeast-Escherichia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites. Gene 74:527-534.[CrossRef][Medline]
9. Gilbert, C. S., C. M. Green, and N. F. Lowndes. 2001. Budding yeast Rad9 is an ATP-dependent Rad53 activating machine. Mol. Cell 8:129-136.[CrossRef][Medline]
10. Green, C. M., H. Erdjument-Bromage, P. Tempst, and N. F. Lowndes. 2000. A novel Rad24 checkpoint protein complex closely related to replication factor C. Curr. Biol. 10:39-42.[CrossRef][Medline]
11. Katou, Y., Y. Kanoh, M. Bando, H. Noguchi, H. Tanaka, T. Ashikari, K. Sugimoto, and K. Shirahige. 2003. S-phase checkpoint proteins Tof1 and Mrc1 form a stable replication-pausing complex. Nature 424:1073-1083.
12. Kondo, T., K. Matsumoto, and K. Sugimoto. 1999. Role of a complex containing Rad17, Mec3, and Ddc1 in the yeast DNA damage checkpoint pathway. Mol. Cell. Biol. 19:1136-1143.
13. Kondo, T., T. Wakayama, T. Naiki, K. Matsumoto, and K. Sugimoto. 2001. Recruitment of Mec1 and Ddc1 checkpoint proteins to double-strand breaks through distinct mechanisms. Science 5543:867-870.
14. Longhese, M. P., M. Foiani, M. Muzi-Falconi, G. Lucchini, and P. Plevani. 1998. DNA damage checkpoint in budding yeast. EMBO J. 17:5525-5528.[CrossRef][Medline]
15. Mallory, J. C., and T. D. Petes. 2000. Protein kinase activity of Tel1p and Mec1p, two Saccharomyces cerevisiae proteins related to the human ATM protein kinase. Proc. Natl. Acad. Sci. USA 97:13749-13754.
16. Melo, J. A., J. Cohen, and D. P. Toczyski. 2001. Two checkpoint complexes are independently recruited to sites of DNA damage in vivo. Genes Dev. 21:2809-2821.
17. Morrow, D. M., D. A. Tagle, Y. Shiloh, F. S. Collins, and P. Hieter. 1995. TEL1, an S. cerevisiae homolog of the human gene mutated in ataxia telangiectasia, is functionally related to the yeast checkpoint gene MEC1. Cell 82:831-840.[CrossRef][Medline]
18. Naiki, T., T. Shimomura, T. Kondo, K. Matsumoto, and K. Sugimoto. 2000. Rfc5, in cooperation with Rad24, controls DNA damage checkpoints throughout the cell cycle in Saccharomyces cerevisiae. Mol. Cell. Biol. 20:5888-5896.
19. Nakada, D., K. Matsumoto, and K. Sugimoto. 2003. ATM-related Tel1 associates with double-strand breaks through an Xrs2-dependent mechanism. Genes Dev. 17:1957-1962.
20. Nakada, D., T. Shimomura, K. Matsumoto, and K. Sugimoto. 2003. The ATM-related Tel1 protein of Saccharomyces cerevisiae controls a checkpoint response following phleomycin treatment. Nucleic Acids Res. 31:1715-1724.
21. Paciotti, V., M. Clerici, G. Lucchini, and M. P. Longhese. 2000. The checkpoint protein Ddc2, functionally related to S. pombe Rad26, interacts with Mec1 and is regulated by Mec1-dependent phosphorylation in budding yeast. Genes Dev. 14:2046-2059.
22. Pellicioli, A., S. E. Lee, C. Lucca, M. Foiani, and J. E. Haber. 2001. Regulation of Saccharomyces Rad53 checkpoint kinase during adaptation from DNA damage-induced G2/M arrest. Mol. Cell 7:293-300.[CrossRef][Medline]
23. Reid, R. J., I. Sunjevaric, M. Keddache, and R. Rothstein. 2002. Efficient PCR-based gene disruption in Saccharomyces strains using intergenic primers. Yeast 19:319-328.[CrossRef][Medline]
24. Rouse, J., and S. P. Jackson. 2000. LCD1: an essential gene involved in checkpoint control and regulation of the MEC1 signalling pathway in Saccharomyces cerevisiae. EMBO J. 19:5793-5800.[CrossRef][Medline]
25. Rouse, J., and S. P. Jackson. 2002. Lcd1p recruits Mec1p to DNA lesions in vitro and in vivo. Mol. Cell 9:857-869.[CrossRef][Medline]
26. Saka, Y., F. Esashi, T. Matsusaka, S. Mochida, and M. Yanagida. 1997. Damage and replication checkpoint control in fission yeast is ensured by interactions of Crb2, a protein with BRCT motif, with Cut5 and Chk1. Genes Dev. 11:3387-3400.
27. Sanchez, Y., J. Bachant, H. Wang, F. Hu, D. Liu, M. Tetzlaff, and S. J. Elledge. 1999. Control of the DNA damage checkpoint by chk1 and rad53 protein kinases through distinct mechanisms. Science 286:1166-1171.
28. Sanchez, Y., B. A. Desany, W. J. Jones, Q. Liu, B. Wang, and S. J. Elledge. 1996. Regulation of RAD53 by the ATM-like kinase MEC1 and TEL1 in yeast cell cycle checkpoint pathways. Science 271:357-360.[Abstract]
29. Schwartz, M. F., J. K. Duong, Z. Sun, J. S. Morrow, D. Pradhan, and D. F. Stern. 2002. Rad9 phosphorylation sites couple Rad53 to the Saccharomyces cerevisiae DNA damage checkpoint. Mol. Cell 9:1055-1065.[CrossRef][Medline]
30. Sugimoto, K., S. Ando, T. Shimomura, and K. Matsumoto. 1997. Rfc5, replication factor C component, is required for regulation of Rad53 protein kinase in the yeast checkpoint pathway. Mol. Cell. Biol. 17:5905-5914.[Abstract]
31. Sun, Z., D. S. Fay, F. Marini, M. Foiani, and D. F. Stern. 1996. Spk1/Rad53 is regulated by Mec1-dependent protein phosphorylation in DNA replication and damage checkpoint pathways. Genes Dev. 10:395-406.
32. Sun, Z., J. Hsiao, D. S. Fay, and D. F. Stern. 1998. Rad53 FHA domain associated with phosphorylated Rad9 in the DNA damage checkpoint. Science 281:272-274.
33. Toczyski, D. P., D. J. Galgoczy, and L. H. Hartwell. 1997. CDC5 and CKII control adaptation to the yeast DNA damage checkpoint. Cell 90:1097-1106.[CrossRef][Medline]
34. Vialard, J. E., C. S. Gilbert, C. M. Green, and N. F. Lowndes. 1998. The budding yeast Rad9 checkpoint protein is subjected to Mec1/Tel1-dependent hyperphosphorylation and interacts with Rad53 after DNA damage. EMBO J. 17:5679-5688.[CrossRef][Medline]
35. Wakayama, T., T. Kondo, S. Ando, K. Matsumoto, and K. Sugimoto. 2001. Pie1, a protein interacting with Mec1, controls cell growth and checkpoint responses in Saccharomyces cerevisiae. Mol. Cell. Biol. 21:755-764.
36. Weinert, T. A., and L. H. Hartwell. 1988. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241:317-322.
37. White, C. I., and J. E. Haber. 1990. Intermediates of recombination during mating type switching in Saccharomyces cerevisiae. EMBO J. 9:663-673.[Medline]
38. Zhao, X., E. G. D. Muller, and R. Rothstein. 1998. A suppressor of two essential checkpoint genes identifies a novel protein that negatively affects dNTP pool. Mol. Cell 2:329-340.[CrossRef][Medline]
39. Zhou, B.-B. S., and S. J. Elledge. 2000. The DNA damage response: putting checkpoints in perspective. Nature 408:433-439.[CrossRef][Medline]
40. Zou, L., and S. J. Elledge. 2003. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300:1542-1548.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|